Corrigendum to “Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy” [Bioact. Mater. 34 (2024) 466–481]
Cancer patients by immune checkpoint therapy have achieved long-term remission, with no recurrence of clinical symptoms of cancer for many years. Nevertheless, more than half of cancer patients are not responsive to this therapy due to immune exhaustion. Here, we report a novel gene engineered exoso...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
KeAi Communications Co., Ltd.
2025-10-01
|
| Серія: | Bioactive Materials |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2452199X25002130 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|